Next Article in Journal
In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts
Previous Article in Journal
e-Health in Cardiovascular Medicine
Article Menu

Export Article

Open AccessArticle

Immune Status of Pancreatic Cancer Patients Receiving Cryosurgery

A.V. Vishnevsky National Medical Research Center of Surgery, Moscow 117997, Russia
Department of Research and Development at Facecontrol, Inc., Miami, FL 33131, USA
Department of Microbiology of Burdenko, Voronezh State Medical University, Voronezh 394000, Russia
Author to whom correspondence should be addressed.
Med. Sci. 2019, 7(6), 73;
Received: 12 April 2019 / Accepted: 13 June 2019 / Published: 22 June 2019
PDF [2827 KB, uploaded 26 June 2019]


Cryosurgery used on patients with unresectable pancreatic cancer improved their quality of life, but mainly because of the pain relief. In postoperative patients, multifaceted changes in immunity were found, and the state of the immune system prior to surgery often was a decisive factor to indicate whether further disorders in the postoperative period would develop, or by contrast, it would boost its recovery. Some patients receiving cryosurgery showed immune system imbalance and activation, and of antitumor immunity in particular. It has been suggested that the advisability of immunotropic therapy for specific treatment algorithms should be predicted or the therapy should be suspended at some pathologic stage, and this has been immunologically confirmed. Cryosurgery should be considered as a reasonable alternative to the existing types of surgery for pancreatic cancer or as an essential component of multimodal therapy, consisting of topical cryosurgery, chemotherapy, and immunotropic therapy, to boost antitumor immunity and to discontinue cytoreductive therapy due to its toxic effects. View Full-Text
Keywords: pancreatic cancer; cryosurgery; immune status pancreatic cancer; cryosurgery; immune status

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zemskov, V.M.; Pronko, K.N.; Ionkin, D.A.; Chzhao, A.V.; Kozlova, M.N.; Barsukov, A.A.; Shishkina, N.S.; Demidova, V.S.; Zemskov, A.M.; Revishvili, A.S. Immune Status of Pancreatic Cancer Patients Receiving Cryosurgery. Med. Sci. 2019, 7, 73.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Med. Sci. EISSN 2076-3271 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top